Figure 1From: Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study Patient disposition. *Patients could provide more than one reason for discontinuation. DMARD, disease-modifying anti-rheumatic drug; TNF, tumor necrosis factor.Back to article page